Private Trust Company’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4K Sell
43
-51
-54% -$4.52K ﹤0.01% 2244
2025
Q4
$7.55K Sell
94
-2,089
-96% -$175K ﹤0.01% 2036
2025
Q3
$213K Buy
2,183
+2,140
+4,977% +$172K 0.02% 730
2025
Q2
$3K Hold
43
﹤0.01% 2191
2025
Q1
$2.14K Hold
43
﹤0.01% 2241
2024
Q4
$3K Hold
43
﹤0.01% 2115
2024
Q3
$4.51K Hold
43
﹤0.01% 1983
2024
Q2
$6.11K Hold
43
﹤0.01% 1853
2024
Q1
$4.79K Sell
43
-270
-86% -$32.2K ﹤0.01% 1938
2023
Q4
$40.6K Buy
313
+270
+628% +$37.2K ﹤0.01% 1135
2023
Q3
$7.01K Buy
43
+18
+72% +$3.17K ﹤0.01% 1741
2023
Q2
$4.58K Hold
25
﹤0.01% 1905
2023
Q1
$3.33K Buy
+25
New +$2.94K ﹤0.01% 1969

Other funds holding ACLS

Private Trust Company's ACLS Position: Q1 2026 in Review

Private Trust Company reduced its Axcelis (ACLS) stake by 54% in Q1 2026, selling an estimated $4.52K and leaving 43 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #2244.

Private Trust Company first reported a position in ACLS in Q1 2023 and has held it in 13 quarters since. The position peaked at $213K in Q3 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Private Trust Company held 43 shares of Axcelis worth $4K as of Q1 2026.
  • Private Trust Company sold 51 Axcelis shares in Q1 2026, an estimated $4.52K.
  • Axcelis made up ﹤0.01% of Private Trust Company's portfolio in Q1 2026, its #2244 holding.
  • Private Trust Company first reported a position in Axcelis in Q1 2023 and has held it in 13 quarters since.
  • Private Trust Company's Axcelis position peaked at $213K in Q3 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Private Trust Company's 13F filing for Q1 2026, filed 30 Apr 2026.